- SID Score
- 5.1/10
- Fair value
- $746.73
- Generated
- Oct 10, 2026
- Model
- claude-haiku-4-5-20251001
The Goldman Sachs Group, Inc. (GS) is trading at $895.32 with a market capitalization of $285.8 billion and a P/E ratio of 16.92, suggesting moderate valuation relative to earnings. The stock carries a SID Score of 5.1/10, indicating below-average investment quality, with fair value estimated at $746.73 representing 17.3% downside from current levels. Analyst consensus remains neutral with an average price target of $776.60, and recent earnings have shown mixed performance against estimates, with Q2 2026 significantly beating expectations at $20.98 EPS versus $14.10 estimated.
Goldman Sachs demonstrates mediocre fundamental health with factor grades showing C-ratings in Value and Profitability, while Growth and Momentum both received D-grades, indicating structural weaknesses across multiple dimensions. The dividend yield of 0.02% is exceptionally low, reflecting minimal income generation for shareholders and a D-grade in dividend quality despite the C-factor rating. Recent earnings performance is inconsistent, with Q2 2026 beating estimates by 49% but subsequent quarters showing less clarity, suggesting operational volatility rather than sustainable earnings power. The current P/E of 16.92 appears elevated relative to the company's growth prospects and profitability metrics, particularly given the fair value estimate implying significant overvaluation.
The stock is in a weakened technical position with an RSI(14) of 28.4, indicating oversold conditions and potential for a bounce, yet price remains elevated relative to moving averages. GS is currently trading $97.20 below its 50-day moving average of $992.52 and $58.40 above its 200-day moving average of $953.72, suggesting short-term weakness within an intermediate uptrend. This configuration indicates that while the longer-term trend remains slightly positive, recent momentum has deteriorated significantly, creating potential support near the 200-day average. The technical setup suggests caution, with resistance likely near the 50-day MA and support around $950-960.
Analyst & Insider Sentiment
Insider activity presents a notably bearish signal, with Leslie Ericka T conducting substantial share sales totaling approximately 35,427 shares across multiple transactions in August 2026, while only one offsetting buy signal from Peter Oppenheimer (7,342 shares in July) has occurred. The pattern of continuous insider selling, particularly the concentrated sales in early August, suggests negative conviction among company leadership regarding near-term prospects. Analyst consensus of "Hold" with an average price target of $776.60 implies 13.3% downside, directly contradicting the current price and reinforcing skepticism about valuation sustainability. The neutral news sentiment combined with these signals does not inspire confidence in the stock's near-term direction.
Major risks include valuation compression if earnings fail to support the current price-to-earnings multiple, particularly given the Growth and Momentum factor grades of D, which typically precede multiple contraction. Interest rate sensitivity represents another significant risk for financial services firms, and any economic deterioration could impact Goldman Sachs' investment banking and trading revenue streams substantially. The exceptionally low dividend yield provides minimal downside cushion for equity holders, and the insider selling pattern suggests management may have concerns about stock sustainability at these levels. Additionally, regulatory risks inherent in investment banking and capital markets operations could materially impact profitability.
Goldman Sachs presents a cautious "Hold" case at current levels, with the stock appearing overvalued relative to its 17.3% fair value discount and receiving consensus bearish guidance from both analysts and corporate insiders. The combination of weak growth prospects (D-grade), deteriorating momentum, insider selling, and technical oversold conditions creates an unattractive risk-reward profile for new capital deployment. While the recent Q2 earnings beat suggests operational capability, the inconsistent results and low dividend yield offer insufficient compensation for the identified risks. Conservative investors should await a decline toward the $750-780 analyst target or fair value estimate before initiating positions, while existing shareholders may consider trimming exposure given insider action and valuation concerns.
